Journal of the American College of Cardiology Vol. 36, No. 4, by the American College of Cardiology ISSN /00/$20.

Size: px
Start display at page:

Download "Journal of the American College of Cardiology Vol. 36, No. 4, by the American College of Cardiology ISSN /00/$20."

Transcription

1 Journal of the American College of Cardiology Vol. 36, No. 4, by the American College of Cardiology ISSN /00/$20.00 Published by Elsevier Science Inc. PII S (00) Systolic Anterior Motion Begins at Low Left Ventricular Outflow Tract Velocity in Obstructive Hypertrophic Cardiomyopathy Mark V. Sherrid, MD, FACC, David Z. Gunsburg, MD, Sonja Moldenhauer, MD, Gretchen Pearle, RDCS New York, New York Hypertrophic Cardiomyopathy OBJECTIVES BACKGROUND METHODS RESULTS CONCLUSIONS The purpose of this study was to determine whether the dynamic cause for mitral systolic anterior motion (SAM) is a Venturi or a flow drag (pushing) mechanism. In obstructive hypertrophic cardiomyopathy (HCM), if SAM were caused by the Venturi mechanism, high flow velocity in the left ventricular outflow tract (LVOT) should be found at the time of SAM onset. However, if the velocity was found to be normal, this would support an alternative mechanism. We studied with echocardiography 25 patients with obstructive HCM who had a mean outflow tract gradient of 82 6 mm Hg. We compared mitral valve M-mode echocardiogram tracings with continuous wave (CW) and pulsed wave (PW) Doppler tracings recorded on the same study. A total of 98 M-mode, 159 CW, and 151 PW Doppler tracings were digitized and analyzed. For each patient we determined the LVOT CW velocity at the time of SAM onset. This was done by first determining the mean time interval from Q-wave to SAM onset from multiple M-mode tracings. Then, CW velocity in the outflow tract was measured at that same time interval following the Q wave. Systolic anterior motion began mean 71 5 ms after Q-wave onset. Mean CW Doppler velocity in the LVOT at SAM onset was 89 8 cm/s. In 68% of cases SAM began before onset of CW and PW Doppler LV ejection. Systolic anterior motion begins at normal LVOT velocity. At SAM onset, though Venturi forces are present in the outflow tract, their magnitude is much smaller than previously assumed; the Venturi mechanism cannot explain SAM. These velocity data, along with shape, orientation and temporal observations in patients, indicate that drag, the pushing force of flow, is the dominant hydrodynamic force that causes SAM. (J Am Coll Cardiol 2000;36: ) 2000 by the American College of Cardiology Systolic anterior motion (SAM) of the mitral valve is the cause of dynamic outflow obstruction in most patients with hypertrophic cardiomyopathy (HCM). There is agreement that SAM is caused by the action of left ventricular (LV) flow on the protruding mitral valve leaflet (1). The nature of the hemodynamic force on the leaflet remains a subject of unresolved debate (2 5). Initially, investigators hypothesized that anterior motion is caused by a Venturi mechanism, whereby high velocity flow in the outflow tract lifts the mitral valve toward the septum. More recent investigations indicate that drag, the pushing force of flow, is the dominant hydrodynamic force that initiates anterior motion, pushing the protruding mitral leaflet into the septum (6 9). Flow drag is the component of force on a body that is in the direction of the flow examples are the familiar pushing force of rushing water or the wind. One of these From the HCM Program, Division of Cardiology, St. Luke s Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, New York. Presented in part at the American Heart Association Annual Scientific Sessions, Atlanta, Georgia, November 8, Grants were provided by Mr. John Lium and Mr. Munio Podhorzer. Manuscript received December 8, 1999; revised manuscript received March 20, 2000, accepted May 1, studies used normal canine subjects and one was an in vitro investigation. Two were studies of HCM patients. Despite these investigations, prominent sources describe a Venturi mechanism for SAM (3 5). Thus, the present study of obstructed HCM patients was undertaken in an attempt to clarify this question. Whenever flow traverses a surface such as the mitral valve, both lift and drag forces are generated. Pertinent to the present study is that lift-to-drag ratio falls with decreasing velocity (10,11). During an earlier study we noticed that color flow velocity in the left ventricular outflow tract (LVOT) seemed low when SAM began, as deduced by others previously (8). In the present study we reasoned that if SAM were caused by the Venturi mechanism, we should find high velocity flow in the LVOT at the moment of SAM onset. Conversely, if we found low velocity at that time, this would support a flow drag mechanism. These early systolic velocities have not previously been measured. Consequently, we have systematically studied the echocardiograms of patients with significant obstruction, specifically measuring velocity of early systolic outflow at SAM onset.

2 JACC Vol. 36, No. 4, 2000 October 2000: Sherrid et al. Systolic Anterior Motion Begins at Low Outflow Tract Velocity 1345 Abbreviations and Acronyms CW continuous wave HCM hypertrophic cardiomyopathy LV left ventricle, left ventricular LVOT left ventricular outflow tract PW pulsed wave SAM systolic anterior motion METHODS Patients. We prospectively studied 25 consecutive patients with obstructive HCM who had resting LV outflow gradients greater than 36 mm Hg and technically adequate echocardiograms. Mean age was 63 years (27 to 86 years); 11 were women. Patients were referred for clinical indications; medications were continued at the time of the study. All patients had asymmetric LV hypertrophy with septal thickness 15 mm and had no apparent cause for the hypertrophy (12). None had hypertension or aortic valve disease. All had SAM and mitral septal contact. The peak pressure gradient across the LVOT was determined using continuous wave (CW) Doppler in the apical five-chamber view (13). All patients were in sinus rhythm. Echocardiogram acquisition, selection and measurement. Studies were performed at rest in the left lateral decubitus position using Hewlett-Packard Sonos 1000 echocardiographs. M-MODE ECHOCARDIOGRAM. The M-mode echocardiogram recordings were made from the parasternal window during the same examination and within 5 min of the Doppler tracings. A modified electrocardiographic (ECG) lead I was continuously recorded. The mitral valve area of interest was magnified and recorded at 100 mm/s sweep speed. Views showing the mitral coaptation point and the most SAM of the mitral valve were recorded on videotape. The M-mode views were correlated with the twodimensional (2-D) view to avoid mistakenly recording chordal SAM. Tracings of SAM with both a clear mitral coaptation point and continuity with mitral septal apposition were subsequently selected for measurement using a Nova Microsonics analysis computer. We measured the time interval from Q-wave onset till the first abrupt systolic anterior movement of the mitral valve. We measured the RR interval for each M-mode beat selected. Figure 1 illustrates the M-mode and Doppler measurements. Figure 1. (Left) Continuous wave (CW) Doppler tracings were recorded in the five-chamber view through the LVOT as shown by the dashed line. Pulsed wave (PW) Doppler tracings were recorded in the LV at a point 2.5 cm apical of the mitral coaptation point and 1 cm from the septum, in LV outflow, as marked with the X. This location is the AMV point, apical of the mitral valve. (Right) The time interval Q-SAM is the interval from Q-wave onset to SAM onset. The velocity V-SAM is the CW velocity in the outflow tract at the time interval Q-SAM. A r atrial reflected wave.

3 1346 Sherrid et al. JACC Vol. 36, No. 4, 2000 Systolic Anterior Motion Begins at Low Outflow Tract Velocity October 2000: CONTINUOUS WAVE DOPPLER. Continuous wave (CW) Doppler was performed from the apex, through the area of mitral septal contact. We avoided contamination of this signal by flow from mitral regurgitation and by flow from the aortic valve or aorta. Doppler flow velocity tracings were recorded on videotape at 100 mm/s sweep speed. PULSED WAVE DOPPLER. In the apical five-chamber view, the pulsed Doppler sample volume was placed in the LV, 2.5 cm apical of the mitral valve coaptation point and 1 cm from the interventricular septum, near the centerline of ejection color flow. We refer to this point as the AMV point, apical of the mitral valve (14,15). The 2-D image apical of the mitral valve was magnified to assure proper placement of the sample volume. We recorded beats that had high peak velocities and minimal spectral dispersion. Small sample volume and low filter settings were used. DOPPLER TRACE SELECTION AND MEASUREMENTS. Beats were excluded if they did not show laminar flow, or showed an attenuated envelope. We selected several M-mode, pulsed wave (PW), and CW Doppler beats matched for similar RR intervals; for individual patients there was 3% variation in mean RR intervals between modalities. Selected Doppler traces were digitized into the analysis computer. Doppler and M-mode measurements were made by different investigators. For Doppler traces, we measured the preejection period as the time from the beginning of the ECG Q wave to the onset of ejection. THE LV OUTFLOW VELOCITY AT SAM ONSET. For each patient we determined the LVOT CW velocity at the time of SAM onset. This was done by first determining the mean time interval from Q-wave onset to SAM onset from multiple M-mode tracings. Next, we measured the CW velocity in the outflow tract at that same time interval following the Q wave. The CW trace with the closest RR interval to the mean M-mode RR interval was selected. On this tracing we digitally magnified the early systolic area of interest. Using digital calipers, the CW velocity at the time of SAM onset was determined by two independent observers. This measurement is shown in Figure 1. The average velocity measurement of the two observers was determined, as was the interobserver variation. As we found that SAM began before ejection onset in more than half the patients, we examined the Doppler LV intraventricular flow that occurred during this preejection period. During this time, the A r wave is a prominent preejection flow (16 19). Both peak A r velocity and the time from Q-wave onset to peak A r velocity were measured. Statistics. Continuous data are presented as mean SEM (range). The Student group t tests were calculated for comparisons of means. Relations between different variables were assessed by Pearson s correlation coefficient. Significance level was based on a two-tailed test. A value of p 0.05 was considered significant. RESULTS In the 25 patients, a total of 98 M-mode tracings, 159 CW Doppler tracings and 151 PW Doppler tracings were digitized and analyzed. There were an average of 4 M-mode, 7 CW Doppler and 6 PW Doppler tracings per patient. The mean peak LVOT gradient was 82 6 mm Hg (range 40 to 150). The mean time of SAM onset was 71 5 ms (range 34 to 155 ms) after the ECG Q wave. The mean CW Doppler velocity in the LVOT at the time of SAM onset was 89 8 cm/s (range 43 to 193). In 67% of the patients, SAM began at velocities of less than 100 cm/s. Representative tracings in six patients are shown in Figures 2 and 3. Data on the 25 patients are shown in Table 1. There was little interobserver variability between the measured CW velocities at SAM onset. The mean interobserver difference was 8 cm/s (range 1 to 26); correlation between the two measurements was good, r The RR intervals. In the 25 patients as a group, little difference was seen in the mean RR intervals of the analyzed M-mode, CW and PW Doppler tracings; the mean RR intervals were , , and ms, respectively. For individual patients, the mean difference between the average RR intervals of the M-mode and CW tracings was 24 3 ms (range 2 to 48 ms). The mean difference between the average RR intervals of the M-mode and PW tracings was 20 3 ms (range 0 to 48 ms). Preejection SAM. In 17 patients (68%), the onset of SAM occurred before the onset of ejection flow recorded on both CW and PW Doppler. In these patients with preejection SAM, M-mode SAM began earlier than in the patients with SAM beginning after ejection onset, at 62 4 compared with ms after Q-wave onset (p 0.03). Examples of patients with early SAM are shown in Figures 2 and 3. INTRAVENTRICULAR FLOW DURING THE PREEJECTION PE- RIOD. We observed preejection flow both within the LV and also within the LVOT in all patients. The predominant flow during this time period is the A r wave, seen as a flow directed away from the transducer (16 19), shown in Figures 1 through 3. In the LV at the AMV point, the mean peak velocity of the A r wave was 69 4 cm/s (range 35 to 108); mean acceleration to peak of the A r wave was 1, cm/sec 2. Peak A r wave velocity occurred 53 4ms after Q-wave onset. DISCUSSION In this study we have found that Doppler velocity measurements in the LVOT do not support the hypothesis that Venturi forces cause SAM. Whenever flow traverses a surface such as the mitral valve, both lift and drag forces are generated. Drag, the pushing force of flow, is the component of force that is in the same direction as flow. An example is the pushing force of water on the paddle of a

4 JACC Vol. 36, No. 4, 2000 October 2000: Sherrid et al. Systolic Anterior Motion Begins at Low Outflow Tract Velocity 1347 Figure 2. M-mode (top), continuous wave (middle), and pulsed wave Doppler (bottom) tracings of two patients. Patient 3 is on the left and patient 14 is on the right. In both patients, the left dashed line indicates time of Q-wave onset. The right solid line indicates the time of SAM onset. In both patients SAM onset begins at a time of low velocity both in the outflow tract and in the LV. In both patients SAM begins before the onset of ejection, during the A r wave (16 19). Both M-mode and Doppler tracings were recorded on the same study, within a 5-min interval, and were selected for matched RR intervals. Vertical calibrations of CW and PW tracings are at 1-m/s and 20-cm/s intervals, respectively. waterwheel. Lift refers to Venturi forces produced by high velocity flow over the surface of an object causing the object to move perpendicular to flow. An example is the force produced as a horizontal airplane wing moves through the air, lifting it vertically. For any object the relative importance of lift as compared with drag is dependent upon three factors: 1) velocity of flow, 2) shape, and 3) orientation relative to flow (10,11). Velocity. It is the central premise of the Venturi theory of SAM that high velocity ejection flow causes a local underpressure in the LVOT, which pulls the protruding mitral leaflet toward the septum. In this study, we show that SAM actually begins very early in systole at a time when velocity in the LVOT is normal. Specifically, SAM begins at a time when mean outflow tract velocity is 89 cm/s (range 43 to 193), a velocity not unlike that routinely recorded in the LVOT of normal patients without SAM (20). Decreased velocity significantly decreases lift in two ways, and decreases its importance compared with drag forces. First, lift falls because it is roughly proportional to the square of velocity. Second, for any given shape, the ratio of lift to drag falls with decreasing velocity (10,11). At lower velocity, profile drag increases because increased contact of the fluid with the surface leads to increased friction with flow. Lower velocity

5 1348 Sherrid et al. JACC Vol. 36, No. 4, 2000 Systolic Anterior Motion Begins at Low Outflow Tract Velocity October 2000: Figure 3. Four patients with obstructive HCM. In all cases the M-mode echocardiograms showing SAM onset are on top and the Doppler tracings are below. For the two patients on the left, the M-mode is compared with the CW Doppler tracings in the LVOT. For the two patients on the right, the M-mode is compared with the PW Doppler tracings in the LV at the AMV point. In all, the left dashed line indicates Q-wave onset. The right solid line indicates SAM onset. In all four patients SAM onset occurs at a time of low velocity, before the beginning of ejection. In the two patients on the right, SAM onset begins during the A r wave. Both M-mode and Doppler tracings were recorded on the same study, within a 5-min interval, and were selected for matched RR intervals. Vertical calibrations of CW and PW Doppler tracings are at 1-m/s and 20-cm/s intervals, respectively. allows viscosity to do its work. The difficulty of flying at low speed is an example of falling lift/drag ratio at lower velocity. The modest outflow velocities we have measured indicate that, at the time of SAM onset, the magnitude of the Venturi force is much smaller than previously assumed; high velocities needed to generate significant Venturi forces are, in fact, not present. Therefore, the Venturi mechanism cannot be the main cause of SAM. Flow drag: Geometric shape and orientation relative to flow. Besides velocity, the other factors that determine the relative importance of lift and drag are shape and orientation relative to flow (10,11), in this case between the mitral valve and the LV intraventricular flow (6,8). Available data with regard to these geometric relations indicate that drag is the dominant hydrodynamic mechanism for SAM (6 9). In obstructive HCM the mitral valve leaflets are anteriorly positioned, relatively large, and residual portions of leaflets extend past the coaptation point and protrude into the outflow tract (1,7,21 23). The anterior displacement puts the mitral valve into the edge of the flow stream of LV ejection, subjecting the mitral valve to the hemodynamic force of ejection flow (1). This LVOT narrowing and anterior position of the mitral coaptation point can be cited as evidence for either Venturi or drag (pushing) mechanisms, as the narrowing could play a role in both mechanisms. On the one hand, flow velocity must increase as it enters the narrowed outflow tract producing Venturi (lift) forces (24,25). Such Venturi forces are necessarily present. On the other hand, narrowing of the LVOT and the anterior position of the coaptation point also places the protruding leaflet into the edge of the flow stream, subject to the pushing force of flow that strikes the undersurface of the leaflet (6 9,23). The flow drag mechanism is illustrated in Figure 4. Thus, the LVOT narrowing provides the substrate for, and is evidence to support, both theories. This has been a source of confusion in the debate. Additional data show that drag forces are more important than Venturi for causing SAM. Canine and in vitro experiments. Without septal hypertrophy, SAM and obstruction can be induced in normal dogs by anterior displacement of the papillary muscles with ligatures (7). In an in vitro model, SAM does not occur when the valve has its normal posterior coaptation point, regardless of how high velocities are elevated in the LVOT. Not until the valve is mechanically lifted into the outflow stream and chordal slack is introduced does SAM occur (9,26).

6 JACC Vol. 36, No. 4, 2000 October 2000: Sherrid et al. Systolic Anterior Motion Begins at Low Outflow Tract Velocity 1349 Table 1. Doppler and M-Mode Measurements in 25 Patients With Systolic Anterior Motion (SAM) Patient Age (yrs) Gender LVOTG (mm Hg) QtoSAM (ms) PEP/PW (ms) PEP/CW (ms) vatsam (cm/s) Early SAM 1 72 M M M M F F M M M N/A N/A F * M F M M F * F F Average ( 6) 62 ( 4) 85 ( 4) 82 ( 4) 75 ( 8) Late SAM F M M M F M F F Average ( 14) 92 ( 11) 80 ( 7) 72 ( 6) 117 ( 19) Total Average ( 6) 71 ( 5) 83 ( 4) 78 ( 4) 89 ( 9) *A velocity 100 cm/s was measured in two patients with Early SAM. In these patients, SAM coincided with the A r -wave. In three patients, onset of ejection in PW/CW occurred around the beginning of SAM; those patients were considered as Late SAM. LVOTG left ventricular outflow tract gradient; Q to SAM onset of Q wave to beginning of systolic anterior motion; PEP preejection period (onset of Q wave to ejection); PW pulsed wave Doppler; CW continuous wave doppler; v at SAM velocity at beginning of SAM. In HCM patients: Orientation, shape, temporal and Doppler velocity evidence. In patients, a high angle of attack of Doppler color flow relative to the protruding leaflet of the mitral valve has been found; this orientation precludes significant Venturi effects and implicates drag (6). In the apical five-chamber view, local flow direction comes from an angle lateral of the protruding leaflet. The mean angle at time of mitral coaptation was lateral by 21 ; mean angle just before septal contact increased to 45 (6). At these high angles relative to flow, drag is the dominant hydrodynamic force on the leaflet. This is illustrated in Figure 5. Flow pushes on the underside of the protruding leaflet (6 9), as drawn in Figure 4 and imaged in a patient in Figure 6. Critical overlap exists between the inflow and outflow portions of the LV that allows flow drag to catch the leaflet (6,27). The leaflet is swept by the pushing force of flow into the septum. As it moves toward the septum the angle relative to flow increases and constricting drag forces are correspondingly increased as the leaflet presents a greater surface relative to flow (Fig. 5) (6). An example of this phenomenon is a widely open door in a drafty corridor. The door starts moving slowly; it then accelerates as drag increases because the door presents a larger area, until it slams shut (28). Shape of the mitral valve. The mitral valve was not designed for lift. To the contrary, the valve has a sharp anterior edge with no streamlining, and there is a concavity under the cowl of the protruding leaflet. It resembles other biologic structures with high drag coefficient (Fig. 5) (10). The midseptal bulge. Besides the anterior position of the mitral valve, another contributor to the initial positive angle of attack is the midseptal bulge. In patients with obstructive HCM and resting gradients, hypertrophy of the midventricular septum is the rule, occurring in 92% of patients (29). This midseptal bulge is often associated with basilar or whole septal thickening (29,30). Resting gradients are uncommon in patients with only subaortic basilar septal thickening; in these patients resting gradients are found in just 12% (29). If it were Venturi forces from acceleration into a small outflow tract that caused resting obstruction, then isolated basilar hypertrophy and subaortic narrowing should commonly cause resting obstruction. But this is

7 1350 Sherrid et al. JACC Vol. 36, No. 4, 2000 Systolic Anterior Motion Begins at Low Outflow Tract Velocity October 2000: Figure 4. The pushing force of flow. Intraventricular flow relative to the mitral valve in the apical five-chamber view. In obstructive HCM the mitral leaflet coaptation point is closer to the septum than normal (1). The protruding leaflets extend into the edge of the flowstream and are swept by the pushing force of flow toward the septum. Flow pushes the underside of the leaflets (arrow) (6 9). Note that the midseptal bulge redirects flow so that it comes from a relatively lateral and posterior direction; on the five-chamber view, flow comes from right field or one o clock direction. This contributes to the high angle of attack relative to the protruding leaflets. Also note that the posterior mitral leaflet is shielded and separated from outflow tract flow by the cowl of the anterior leaflet. Venturi flow in the outflow tract cannot be lifting the posterior leaflet because there is little or no area of this leaflet exposed to outflow tract flow. Venturi forces cannot be causing the anterior motion of the posterior leaflet. uncommon; patients with just basilar outflow tract hypertrophy usually just have provocable obstruction. Instead, data indicate that midventricular septal thickening is generally a necessary condition for resting SAM with mitral septal contact (29). We have observed that this occurs because the midseptal bulge forces the outflow to sweep from a relatively posterior and lateral direction in the LV, as shown in Figures 4 and 6. When viewed in the echocardiographic apical five-chamber view, flow comes from right field or one o clock direction. This contributes to a high angle of attack relative to the protruding mitral leaflet (6). Klues and colleagues (30) reported that SAM was more common in patients with several hypertrophied segments rather than with one hypertrophied segment; SAM occurred more often when the proximal segments of the LV were thickened rather than the distal half. Posterior leaflet SAM. The anterior motion of the posterior mitral leaflet is evidence for the drag mechanism. In 89% of patients with SAM and obstruction, the posterior leaflet moves anteriorly as well (31,32). However, the posterior leaflet is separated from the flow in the LVOT by the cowl of the anterior leaflet (Fig. 4). Venturi forces in the LVOT cannot be lifting the posterior leaflet because there is little or no area of the posterior leaflet that is exposed to LVOT flow. In light of this and the previously mentioned Figure 5. (Left) In the example of a wing, as it moves from a position parallel to flow to a more angled orientation, flow separates from the upper surface, lift decreases, and drag increases (10,11). (Top) Lift is the dominant force up to an angle of approximately 15 relative to air flow. (Middle and bottom) Above 15, separation occurs and lift is greatly attenuated because the rapid flow and its local decrease in pressure are no longer in contact with the top surface. Lift is lost, drag forces are dominant, and the wing stalls (10,11). The angle between flow and a surface is referred to as the angle of attack. Streamlines are shown with continuous arrows; forces on the wing are shown with larger gray arrows. (Right) Similarly, in HCM the magnitude of flow drag on the protruding mitral leaflet is directly related to the angle between the local direction of LV flow and the protruding leaflet. (Middle) The angle between the direction of local flow and the protruding leaflet of the mitral valve is the angle of attack,. The anterior position of the protruding leaflet contributes to the angle of attack. Also, the midseptal bulge redirects flow so that local flow comes from a relatively posterior direction as it curves around the septum. Color flow Doppler defines local flow direction (6). Measured angle of attack was high at the moment of coaptation, mean 12 in the parasternal view, and mean 21 in the apical five-chamber view. High angles preclude significant Venturi forces and implicate drag. (Bottom) As the leaflet is pushed toward the septum, both the angle and drag forces increase markedly. observations, it is concluded that the posterior leaflet is pushed anteriorly. This mechanism is shown in Figure 6. Is it likely that the anterior and posterior leaflets, which share a coaptation plane, have different causes for SAM? It is more reasonable that the anterior motion of the anterior leaflet is caused by the same force that triggers the abnormal posterior leaflet motion; both are caused by flow drag. Finally, the last ingredient necessary for SAM is chordal slack. Without a reduction in chordal tension, no SAM would occur because the leaflets would be tethered (8,9,23). Systolic anterior motion can be described as anteriorly directed mitral valve prolapse. This analogy has merit; in both conditions, the mitral valve is often large and is pushed by flow from its normal systolic position, resulting in mitral regurgitation. In summary, geometric data indicate that the necessary conditions for SAM are anterior position of the mitral coaptation point (which puts the valve into the edge of the outflow stream), positive angle of attack between outflow and the protruding leaflet, and chordal slack.

8 JACC Vol. 36, No. 4, 2000 October 2000: Sherrid et al. Systolic Anterior Motion Begins at Low Outflow Tract Velocity 1351 Figure 6. Flow strikes the undersurface and lateral aspect of the mitral valve very early in systole, causing SAM. Two echocardiographic views of one patient with obstructive HCM are shown; resting gradient 54 mm Hg. (Left) Apical five-chamber view. (Top left) The 2-D image shows the protruding mitral leaflet on the first frame in systole that showed mitral coaptation. Arrowhead points to mitral valve. O indicates outflow tract. (Bottom left) The same view showing the first systolic frame with color flow. Color flow is seen lateral to the leaflet tips (arrow). These images show the event graphically drawn in Figure 4. (Right) Apical three-chamber view. (Top right) The 2-D image again shows the protruding mitral leaflet on the first frame in systole that showed mitral coaptation. Arrowhead points to mitral valve. (Bottom right) This shows the same view of the first systolic frame with color flow. Color flow is seen posterior to the leaflet tip (arrow). Note that color flow velocity is low on both views. On 2-D imaging, the next systolic frames showed fully developed SAM on both views. On color flow, the next systolic frames showed aliasing in the outflow tract. The mitral leaflets are medially and anteriorly positioned into the edge of the flow stream. Low velocity flow strikes the undersurface of valve leaflets; they are swept toward the septum by the pushing force of flow. The geometric conditions for SAM are met in another condition where obstruction occurs, despite the absence of septal hypertrophy. Following mitral annuloplasty certain patients develop, as a complication, SAM. The mitral coaptation point has been shown to be anteriorly displaced into the outflow tract by the ring (33). Consequently, surgical techniques have been developed to ensure that the postoperative mitral coaptation point is posterior in the LV, explicitly out of the way of the outflow stream with its attendant drag (34,35). In the present work, we have shown that rapid ejection flow velocity in the LVOT is not a necessary condition for SAM. In addition, we found that SAM begins before ejection onset in two-thirds of the patients. That SAM often occurs before ejection begins was first reported in 1987; in 10 patients on 2-D echocardiography SAM was seen to begin before the aortic valve opened (8). These temporal data, confirmed in the present work, support the drag hypothesis, rather than Venturi. In patients with preejection SAM, the early motion has been observed to be associated with a prominent LV preejection flow (36). Figure 7 summarizes the evidence in the debate between Venturi and drag forces as the cause of SAM. Therapeutic implications. Recently, new methods to relieve obstruction have been developed: revised surgical techniques (37 40), dual chamber pacing (41 44) and percutaneous transluminal septal myocardial ablation (45,46). Interventions are not always successful (47), and the reason for heterogeneity in response is not clear (43). Despite active research in treatment, the hemodynamic mechanism of obstruction has hitherto remained controversial (2 5). By clarifying the circumstances and the nature of the dynamic force that causes obstruction, the present study should help explain how novel treatments work and also could permit their refinement. This understanding is of crucial importance for the development of future treatment strategies. New surgical approaches address the problem of the large

9 1352 Sherrid et al. JACC Vol. 36, No. 4, 2000 Systolic Anterior Motion Begins at Low Outflow Tract Velocity October 2000: Figure 7. Evidence in the debate between Venturi (lift) and drag (pushing) force as the dynamic cause for SAM. References are enumerated in the text. ASH asymmetric septal hypertrophy. protruding mitral valve and its contribution to obstruction; the operation described by McIntosh reduces by plication the size of the anterior mitral leaflet, adding this to myomectomy (37). Another frees the bound papillary muscles from the surrounding LV muscle. This allows more normal posterior mitral coaptation, explicitly out of the outflow stream and its drag forces (38,39). As Messmer states: This relieves the obstructive component of the mitral valve, which is rarely due to the often cited and never proved Venturi effect but has its origin rather in pathologic insertion of subvalvular apparatus (38). As discussed above, the impact of the midventricular septal bulge is to redirect LV flow so that it comes from a relatively postero-lateral direction. Consequently, an important goal of myomectomy must be to extend the myomectomy resection far enough down toward the apex to allow flow to track more anteriorly and medially along the surgically reduced septum and away from the mitral valve (23,38,39). Adequate extent of the myomectomy past the tip of the anterior mitral leaflets was stressed by Morrow (48) and others (23). A large decrease in the angle of attack of flow relative to the mitral valve has been shown after successful myomectomy; flow is made more parallel to the mitral valve (49). A recent modification extends resection to the deepest portion of the septum, to ensure complete resection of the midseptal bulge (38,39); 90% of patients had no postoperative SAM. Conversely, failure of myomectomy to alleviate SAM is often due to inadequate excision; in many such cases only the basal septum has been resected without resection farther down to the midventricle (47,50,51). Such considerations also apply to site selection for percutaneous alcohol ablation procedures. Targeting the basal septum alone will likely be inadequate; the midventricular bulge must also be addressed for complete relief of obstruction. Dual chamber pacing with complete ventricular preexcitation through short atrioventricular delay significantly reduces outflow tract gradients (41 44). However, therapeutic effect is often incomplete; SAM persists with mean gradients of 30 to 55 mm Hg after three months of pacing (43,44). The mechanism by which pacing benefits SAM is unclear at this time (52). One hypothesis is that pacing might cause asynchronous or paradoxical septal motion, widening the outflow tract and decreasing Venturi forces (42). However, septal paradox is only rarely seen (41,52). Jeanrenaud (52) did find a modest decrease in regional septal wall motion but there was no uniform correlation between the magnitude of decreased septal motion and percent gradient reduction. Also, the present research indicates that a decrease in Venturi forces can only play a minor role in SAM improvement. Therefore, both direct observations and pathophysiology indicate that the mechanism by which pacing reduces SAM is more complex than just a widening of the outflow tract (52). Study limitations. The M-mode tracings of SAM and Doppler tracings were not done simultaneously. Rather, they were done sequentially, within 5 min. This could have influenced results. However, tracings for M-mode, CW, and PW Doppler analyses were selected for matched RR intervals, and many tracings were selected and measured (4 M-mode and 7 CW Doppler beats). The mean RR intervals between modalities were quite close. For individual patients, the mean difference between the average RR intervals of the M-mode and CW tracings was 24 3 ms (range 2 to 48 ms). No patients with atrial fibrillation were examined in this study. Interventricular pressures were not directly measured. In the parasternal M-mode view, as the mitral valve moves anteriorly, the point with SAM onset and the point of mitral septal contact may not be on the same M-mode line. For this study, clear registration of SAM onset was deemed essential, sometimes to the detriment of the point of mitral septal contact. Conclusions. In patients with obstructive HCM we have shown that the onset of SAM of the mitral valve is a low velocity phenomenon. At SAM onset, though Venturi forces are necessarily present in the outflow tract, their magnitude is much smaller than previously assumed. This velocity data, combined with other experimental, geometrical and temporal observations, indicate that drag, the pushing force of flow, is the dominant hydrodynamic mechanism for SAM. Acknowledgment We would like to acknowledge the work of Mrs. Carmen Stockfisch who prepared this manuscript.

10 JACC Vol. 36, No. 4, 2000 October 2000: Sherrid et al. Systolic Anterior Motion Begins at Low Outflow Tract Velocity 1353 Reprint requests and correspondence: Dr. Mark V. Sherrid, Division of Cardiology, 3B-30, 1000 Tenth Avenue, New York, New York REFERENCES 1. Henry WL, Clark CE, Griffith JM, Epstein SE. Mechanism of left ventricular outflow obstruction in patients with obstructive asymmetric septal hypertrophy (idiopathic hypertrophic subaortic stenosis). Am J Cardiol 1975;35: Wigle ED, Rakowski H, Kimball BP, William WG. Hypertrophic cardiomyopathy clinical spectrum and treatment. Circulation 1995; 92: Wynne J, Braunwald E. The cardiomyopathies and myocardities. In: Braunwald E, editor. Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia: Saunders, 1997:1418, Maron BJ, Roberts WC. Hypertrophic cardiomyopathy. In: Schlant RC, Alexander RW, editors. The Heart. New York: McGraw-Hill, 1994: McKenna WJ, Eliot PM. Hypertrophic cardiomyopathy. In: Topol EJ, editor. Comprehensive Cardiovascular Medicine. Philadelphia New York: Lipincott-Raven, 1998: Sherrid MV, Chu CK, Delia E, Mogtader A, Dwyer EM Jr. An echocardiographic study of the fluid mechanics of obstruction in hypertrophic cardiomyopathy. J Am Coll Cardiol 1993;22: Levine RA, Vlahakes GJ, Lefebvre X, et al. Papillary muscle displacement causes systolic anterior motion of the mitral valve. Circulation 1995;91: Jiang L, Levine RA, King ME, Weyman AE. An integrated mechanism for systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy based on echocardiographic observations. Am Heart J 1987;113: Cape EG, Simons D, Jimoh A, Weyman AE, Yognathan AP, Levine RA. Chordal geometry determines the shape and extent of systolic anterior motion: in vitro studies. J Am Coll Cardiol 1989;13: Vogel S. Life in Moving Fluids: The Physical Biology of Flow. Princeton, NJ: Princeton University Press, 1994;88 105, Fox R, McDonald A. Introduction to Fluid Mechanics. 3rd ed. New York: Wiley, 1985: Maron BJ, Epstein SE. Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol 1979;43: Sasson Z, Yock PG, Hatle LK, Alderman EL, Popp RL. Doppler echocardiographic determination of the pressure gradient in hypertrophic cardiomyopathy. J Am Coll Cardiol 1988;11: Sherrid MV, Pearle G, Gunsburg DZ. Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy. Circulation 1998;97: Sherrid MV, Gunsburg DZ, Pearle G. Mid-systolic drop in left ventricular ejection velocity in obstructive hypertrophic cardiomyopathy: the lobster claw abnormality. J Am Soc Echocardiogr 1997;10: Panayiotou H, Byrd BF III. Origin and significance of diastolic Doppler flow signals in left ventricular outflow tract. J Am Coll Cardiol 1990;16: Bellhouse BJ. Fluid mechanics of a model mitral valve. J Physiol 1970;207: Pai RG, Suzuki M, Heywood JT, Ferry DR, Shah PM. Mitral A velocity wave transit time to the outflow tract as a measure of left ventricular diastolic stiffness. Circulation 1994;89: Kim WY, Walker PG, Pedersen EM, et al. Left ventricular blood flow patterns in normal subjects: a quantitative analysis by threedimensional magnetic resonance velocity mapping. J Am Coll Cardiol 1995;26: Davidson WR Jr, Pasquale MJ, Fanelli C. A Doppler echocardiographic examination of the normal aortic valve and left ventricular outflow tract. Am J Cardiol 1991; Klues HG, Maron BJ, Dollar AL, Roberts WC. Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy. Circulation 1992;85: Shah PM, Taylor RD, Wong M. Abnormal mitral valve coaptation in hypertrophic obstructive cardiomyopathy: proposed role in systolic anterior motion of mitral valve. Am J Cardiol 1981;48: Reis R, Bolton MR, King JF, Pugh DM, Dunn MI, Mason DT. Anterior superior displacement of papillary muscles producing obstruction and mitral regurgitation in idiopathic hypertrophic subaortic stenosis. Circulation 1974;49 50 Suppl: Wigle ED, Adelman AG, Silver MD. Pathophysiological considerations in muscular subaortic stenosis. In: Wolstenholme GEW, O Connor M, editors. Hypertrophic Obstructive Cardiomyopathy. London: J& JChurchill, 1971: Spirito P, Maron BJ. Significance of left ventricular outflow tract cross-sectional area in hypertrophic cardiomyopathy: a twodimensional echocardiographic assessment. Circulation 1983;67: Lefebvre XP, Yoganathan AP, Levine RA. Insights from in vitro flow visualization into the mechanism of systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy under steady flow conditions. J Biomed Eng 1992;114: Schwammenthal E, Levine RA. Dynamic subaortic obstruction: a disease of the mitral valve suitable for surgical repair? J Am Coll Cardiol 1996;28: Vogel S. Life in Moving Fluids: The Physical Biology of Flow. Princeton, NJ: Princeton University Press, 1994: Wigle ED, Sasson Z, Henderson MA, et al. Hypertrophic cardiomyopathy: the importance of the site and the extent of hypertrophy a review. Prog Cardiovasc Dis 1985;28: Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 1995;26: Spirito P, Maron BJ. Patterns of systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: assessment by two-dimensional echocardiography. Am J Cardiol 1984;54: Maron BJ, Harding AM, Spirito P, Roberts WC, Waller BF. Systolic anterior motion of the posterior mitral leaflet: a previously unrecognized cause of dynamic subaortic obstruction in patients with hypertrophic cardiomyopathy. Circulation 1983;68: Lee KS, Stewart WJ, Lever HM, Underwood PL, Cosgrove DM. Mechanism of outflow tract obstruction causing failed mitral valve repair. Anterior displacement of leaflet coaptation. Circulation 1993; 88: Jebara VA, Mihaileanu S, Acar C, et al. Left ventricular outflow tract obstruction after mitral valve repair. Results of the sliding leaflet technique. Circulation 1993;88(suppl 2): Grossi EA, Steinberg BM, LeBoutillier M, et al. Decreasing incidence of systolic anterior motion after mitral valve reconstruction. Circulation 1994;90(Suppl 2):II Sherrid MV, Gunsburg DZ, Moldenhauer S, Pearle G. Preejection systolic anterior motion in hypertrophic cardiomyopathy. Circulation 1999;100 Suppl: McIntosh CL, Maron BJ, Cannon RO, Klues H. Initial results of combinedanteriormitralvalveplicationandventricularseptalmyotomy myectomy for relief of left ventricular outflow obstruction in patients with hypertrophic cardiomyopathy. Circulation 1992;86 suppl II:II Messmer BJ. Extended myectomy for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg 1994;58: Schoendube FA, Klues HG, Reith S, Flachskampf FA, Hanrath P, Messmer BJ. Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus. Circulation 1995;92:II Kofflard MJ, van Herwerden LA, Waldstein DJ, et al. Initial results of combined anterior mitral leaflet extension and myectomy in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 1996;28: Jeanrenaud X, Goy JJ, Kappenberger L. Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet 1992;339: Fananapazir L, Cannon RO, Tripodi D, Panza JA. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and -adrenergic blocker therapy. Circulation 1992;85: Nishimura RA, Trusty JM, Hayes DL, et al. Dual-chamber pacing for

11 1354 Sherrid et al. JACC Vol. 36, No. 4, 2000 Systolic Anterior Motion Begins at Low Outflow Tract Velocity October 2000: hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. J Am Coll Cardiol 1997;29: Kappenberger L, Linde C, Daubert C, et al. The PIC Study Group. Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. Eur Heart J 1997;18: Seggewiss H, Faber L, Gleichmann U, et al. Percutaneous transluminal septal myocardial ablation (PTSMA) in hypertrophic obstructive cardiomyopathy (HOCM): acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol 1998;31: Knight C, Kurbaan AS, Seggewiss H, et al. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy. Circulation 1997;95: Roberts CS, McIntosh CL, Brown PS, Cannon RO III, Gertz SD, Clark RE. Reoperation for persistent outflow obstruction in hypertrophic cardiomyopathy. Ann Thorac Surg 1991;51: Morrow AG. Hypertrophic subaortic stenosis. Operative methods utilized to relieve left ventricular outflow obstruction. J Thorac Cardiovasc Surg 1978;76: Nakatani S, Schwammenthal E, Lever HM, Levine RA, Lytle BW, Thomas JD. New insights into the reduction of mitral valve systolic anterior motion after ventricular septal myectomy in hypertrophic obstructive cardiomyopathy. Am Heart J 1996;131: Marwick TH, Stewart WJ, Lever HM, et al. Benefits of intraoperative echocardiography in the surgical management of hypertrophic cardiomyopathy. J Am Coll Cardiol 1992;20: Spirito P, Maron BJ, Rosing DR. Morphologic determinants of hemodynamic state after ventricular septal myotomy myectomy in patients with obstructive hypertrophic cardiomyopathy: M-mode and two-dimensional echocardiographic assessment. Circulation 1984;70: Jeanrenaud X, Kappenberger L. Regional wall motion during pacing for hypertrophic obstructive cardiomyopathy. PACE 1997;20:

marked increase in thickness of walls of heart in patient with HCM.

marked increase in thickness of walls of heart in patient with HCM. Surgical Management of Hypertrophic Obstructive Cardiomyopathy Hani K. Najm MD, Msc, FRCSC, FRCS (Glasg Glasg), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi

More information

Journal of the American College of Cardiology Vol. 34, No. 7, by the American College of Cardiology ISSN /99/$20.

Journal of the American College of Cardiology Vol. 34, No. 7, by the American College of Cardiology ISSN /99/$20. Journal of the American College of Cardiology Vol. 34, No. 7, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00464-7 Echocardiographic

More information

Medical Policy and and and and

Medical Policy and and and and ARBenefits Approval: 10/12/2011 Effective Date: 01/01/2012 Revision Date: Code(s): 93799, Unlisted cardiovascular service or procedure Medical Policy Title: Percutaneous Transluminal Septal Myocardial

More information

Bulging Subaortic Septum: An Important Risk Factor for Systolic Anterior Motion After Mitral Valve Repair

Bulging Subaortic Septum: An Important Risk Factor for Systolic Anterior Motion After Mitral Valve Repair Bulging Subaortic Septum: An Important Risk Factor for Systolic Anterior Motion After Mitral Valve Repair Sameh M. Said, MD, Hartzell V. Schaff, MD, Rakesh M. Suri, MD, DPhil, Kevin L. Greason, MD, Joseph

More information

Muscular (hypertrophic) subaortic stenosis (hypertrophic obstructive cardiomyopathy): the evidence for true obstruction

Muscular (hypertrophic) subaortic stenosis (hypertrophic obstructive cardiomyopathy): the evidence for true obstruction Postgraduate Medical Journal (1986) 62, 531-536 Muscular (hypertrophic) subaortic stenosis (hypertrophic obstructive cardiomyopathy): the evidence for true obstruction to left ventricular outflow E. Douglas

More information

Journal of the American College of Cardiology Vol. 34, No. 4, by the American College of Cardiology ISSN /99/$20.

Journal of the American College of Cardiology Vol. 34, No. 4, by the American College of Cardiology ISSN /99/$20. Journal of the American College of Cardiology Vol. 34, No. 4, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00341-1 Changes

More information

Systolic Anterior Motion of Mitral Valve Subchordal Apparatus: A Rare Echocardiographic Pattern in Non- Obstructive Hypertrophic Cardiomyopathy

Systolic Anterior Motion of Mitral Valve Subchordal Apparatus: A Rare Echocardiographic Pattern in Non- Obstructive Hypertrophic Cardiomyopathy Case Report Cardiol Res. 2017;8(5):258-264 Systolic Anterior Motion of Mitral Valve Subchordal Apparatus: A Rare Echocardiographic Pattern in Non- Obstructive Hypertrophic Cardiomyopathy Jezreel L. Taquiso

More information

Surgical Myectomy for HOCM

Surgical Myectomy for HOCM Surgical Myectomy for HOCM Volkmar Falk Deutsches Herzzentrum Berlin Different Pathology of HOCM Impact on surgical strategy Said SM Expert Rev Cardiovasc Ther 2013 Different Pathology of HOCM Impact on

More information

Septal Myectomy, Papillary Muscle Resection, and Mitral Valve Replacement for Hypertrophic Obstructive Cardiomyopathy: A Case Report

Septal Myectomy, Papillary Muscle Resection, and Mitral Valve Replacement for Hypertrophic Obstructive Cardiomyopathy: A Case Report Case Report Septal Myectomy, Papillary Muscle Resection, and Mitral Valve Replacement for Hypertrophic Obstructive Cardiomyopathy: A Case Report Junichiro Takahashi, MD, 1 Yutaka Wakamatsu, MD, 1 Jun Okude,

More information

Utility of Echocardiography

Utility of Echocardiography Hypertrophic Cardiomyopathy and Beyond- Echo Hawaii 2018 Lawrence Rudski MD FRCPC FACC FASE Professor of Medicine Director, Division of Cardiology and Azrieli Heart Center Jewish General Hospital, McGill

More information

The Management of HOCM: What are the Surgical Options

The Management of HOCM: What are the Surgical Options The Management of HOCM: What are the Surgical Options Konstadinos A Plestis, MD System Chief of Cardiac Thoracic and Vascular Surgery Main Line Health Care System Professor Sidney Kimmel Medical College

More information

Cardiac ultrasound protocols

Cardiac ultrasound protocols Cardiac ultrasound protocols IDEXX Telemedicine Consultants Two-dimensional and M-mode imaging planes Right parasternal long axis four chamber Obtained from the right side Displays the relative proportions

More information

How NOT to miss Hypertrophic Cardiomyopathy? Adaya Weissler-Snir, MD University Health Network, University of Toronto

How NOT to miss Hypertrophic Cardiomyopathy? Adaya Weissler-Snir, MD University Health Network, University of Toronto How NOT to miss Hypertrophic Cardiomyopathy? Adaya Weissler-Snir, MD University Health Network, University of Toronto Introduction Hypertrophic cardiomyopathy is the most common genetic cardiomyopathy,

More information

Hypertrophic Cardiomyopathy: basics and management

Hypertrophic Cardiomyopathy: basics and management Hypertrophic Cardiomyopathy: basics and management Bette Kim, MD Program Director, Cardiomyopathy Program Director, Roosevelt Hospital Echocardiography Lab Assistant Professor of Clinical Medicine Mount

More information

HYPERTROPHIC CARDIOMYOPATHY

HYPERTROPHIC CARDIOMYOPATHY 1641 HYPERTROPHIC CARDIOMYOPATHY Quantitative Assessment of the Operative Results After Extended Myectomy and Surgical Reconstruction of the Subvalvular Mitral Apparatus in Hypertrophic Obstructive Cardiomyopathy

More information

PART II ECHOCARDIOGRAPHY LABORATORY OPERATIONS ADULT TRANSTHORACIC ECHOCARDIOGRAPHY TESTING

PART II ECHOCARDIOGRAPHY LABORATORY OPERATIONS ADULT TRANSTHORACIC ECHOCARDIOGRAPHY TESTING PART II ECHOCARDIOGRAPHY LABORATORY OPERATIONS ADULT TRANSTHORACIC ECHOCARDIOGRAPHY TESTING STANDARD - Primary Instrumentation 1.1 Cardiac Ultrasound Systems SECTION 1 Instrumentation Ultrasound instruments

More information

Long-Term Follow-up Impact of Dual-Chamber Pacing on Patients with Hypertrophic Obstructive Cardiomyopathy

Long-Term Follow-up Impact of Dual-Chamber Pacing on Patients with Hypertrophic Obstructive Cardiomyopathy Long-Term Follow-up Impact of Dual-Chamber Pacing on Patients with Hypertrophic Obstructive Cardiomyopathy HU YUE-CHENG, M.D., PH.D.,*, LI ZUO-CHENG, B.S.,*, LI XI-MING, PH.D., M.D.,* DAVID ZHE YUAN, M.D.,*,

More information

Appendix II: ECHOCARDIOGRAPHY ANALYSIS

Appendix II: ECHOCARDIOGRAPHY ANALYSIS Appendix II: ECHOCARDIOGRAPHY ANALYSIS Two-Dimensional (2D) imaging was performed using the Vivid 7 Advantage cardiovascular ultrasound system (GE Medical Systems, Milwaukee) with a frame rate of 400 frames

More information

Index of subjects. effect on ventricular tachycardia 30 treatment with 101, 116 boosterpump 80 Brockenbrough phenomenon 55, 125

Index of subjects. effect on ventricular tachycardia 30 treatment with 101, 116 boosterpump 80 Brockenbrough phenomenon 55, 125 145 Index of subjects A accessory pathways 3 amiodarone 4, 5, 6, 23, 30, 97, 102 angina pectoris 4, 24, 1l0, 137, 139, 140 angulation, of cavity 73, 74 aorta aortic flow velocity 2 aortic insufficiency

More information

Hemodynamic Assessment. Assessment of Systolic Function Doppler Hemodynamics

Hemodynamic Assessment. Assessment of Systolic Function Doppler Hemodynamics Hemodynamic Assessment Matt M. Umland, RDCS, FASE Aurora Medical Group Milwaukee, WI Assessment of Systolic Function Doppler Hemodynamics Stroke Volume Cardiac Output Cardiac Index Tei Index/Index of myocardial

More information

ECHOCARDIOGRAPHY DATA REPORT FORM

ECHOCARDIOGRAPHY DATA REPORT FORM Patient ID Patient Study ID AVM - - Date of form completion / / 20 Initials of person completing the form mm dd yyyy Study period Preoperative Postoperative Operative 6-month f/u 1-year f/u 2-year f/u

More information

Mitral valve apparatus in Hypertrophic Cardiomyopathy: a specific assessment?

Mitral valve apparatus in Hypertrophic Cardiomyopathy: a specific assessment? Nancy, September 17th, 2015 Mitral valve apparatus in Hypertrophic Cardiomyopathy: a specific assessment? Inserm UMR1087 Institut du Thorax, Nantes Thierry le Tourneau Déclaration de Relations Professionnelles

More information

Assessment of Left Ventricular Outflow Gradient

Assessment of Left Ventricular Outflow Gradient JACC: CARDIOVASCULAR INTERVENTIONS VOL. 5, NO. 6, 2012 2012 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/$36.00 PUBLISHED BY ELSEVIER INC. http://dx.doi.org/10.1016/j.jcin.2012.01.026

More information

Management of HOCM: Non-Surgical Options

Management of HOCM: Non-Surgical Options Management of HOCM: Non-Surgical Options Howard C. Herrmann, MD, FACC, MSCAI John Bryfogle Professor of Cardiovascular Medicine and Surgery Health System Director for Interventional Cardiology Director,

More information

HYPERTROPHIC CARDIOMYOPATHY: Severe Heart Failure. Paolo Spirito, Genoa, Italy

HYPERTROPHIC CARDIOMYOPATHY: Severe Heart Failure. Paolo Spirito, Genoa, Italy HYPERTROPHIC CARDIOMYOPATHY: Severe Heart Failure Paolo Spirito, Genoa, Italy Clinical Substrates for Heart Failure Symptoms in HCM Diastolic dysfunction Atrial fibrillation LV outflow obstruction Evolution

More information

Nancy Goldman Cutler, MD Beaumont Children s Hospital Royal Oak, Mi

Nancy Goldman Cutler, MD Beaumont Children s Hospital Royal Oak, Mi Nancy Goldman Cutler, MD Beaumont Children s Hospital Royal Oak, Mi Identify increased LV wall thickness (WT) Understand increased WT in athletes Understand hypertrophic cardiomyopathy (HCM) Enhance understanding

More information

Surgery for Congenital Heart Disease. 1 Its heterogeneity is well documented in terms of clinical

Surgery for Congenital Heart Disease. 1 Its heterogeneity is well documented in terms of clinical Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae Kenji Minakata, MD a Joseph A. Dearani, MD a Rick A. Nishimura, MD b Barry J. Maron,

More information

HOCM: Alcohol ablation or LVOT Surgery: When and what?

HOCM: Alcohol ablation or LVOT Surgery: When and what? HOCM: Alcohol ablation or LVOT Surgery: When and what? Paul R Vogt/ Pascal A. Berdat Cardiovascular Center Zurich Clinic Im Park Zurich SKG/SGHC Annual Meeting, Zurich, 10.-12.6.15 ASA/Myectomy: Common

More information

Tissue Doppler Imaging in Congenital Heart Disease

Tissue Doppler Imaging in Congenital Heart Disease Tissue Doppler Imaging in Congenital Heart Disease L. Youngmin Eun, M.D. Department of Pediatrics, Division of Pediatric Cardiology, Kwandong University College of Medicine The potential advantage of ultrasound

More information

Normal TTE/TEE Examinations

Normal TTE/TEE Examinations Normal TTE/TEE Examinations Geoffrey A. Rose, MD FACC FASE Sanger Heart & Vascular Institute Before you begin imaging... Obtain the patient s Height Weight BP PLAX View PLAX View Is apex @ 9-10 o clock?

More information

Septal myotomy myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy

Septal myotomy myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy European Heart Journal (2002) 23, 1617 1624 doi:10.1053/euhj.2002.3285, available online at http://www.idealibrary.com on Septal myotomy myectomy and transcoronary septal alcohol ablation in hypertrophic

More information

Outline. EuroScore II. Society of Thoracic Surgeons Score. EuroScore II

Outline. EuroScore II. Society of Thoracic Surgeons Score. EuroScore II SURGICAL RISK IN VALVULAR HEART DISEASE: WHAT 2D AND 3D ECHO CAN TELL YOU AND WHAT THEY CAN'T Ernesto E Salcedo, MD Professor of Medicine University of Colorado School of Medicine Director of Echocardiography

More information

Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy. CardioVascular Research Foundation

Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy. CardioVascular Research Foundation Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy Alcohol Septal Ablation (ASA) Nonsurgical technique for septal myocardial reduction Dramatic hemodynamic improvement Technically easy

More information

Research Proposal. Hypertrophic obstructive cardiomyopathy surgery. Which surgery for which patients?

Research Proposal. Hypertrophic obstructive cardiomyopathy surgery. Which surgery for which patients? Research Proposal Hypertrophic obstructive cardiomyopathy surgery. Which surgery for which patients? An echocardiography, cardiac magnetic resonance and surgical techniques study. Giuseppe Raffa, MD November,

More information

Cardiac hypertrophy and how it may break an athlete s heart e the Cypriot case

Cardiac hypertrophy and how it may break an athlete s heart e the Cypriot case Eur J Echocardiography (2005) 6, 301e307 Cardiac hypertrophy and how it may break an athlete s heart e the Cypriot case C.E. Chee a,1, C.P. Anastassiades a,1, A.G. Antonopoulos b, A.A. Petsas b, L.C. Anastassiades

More information

Variability of Left Ventricular Outflow Tract Gradient During Cardiac Catheterization in Patients With Hypertrophic Cardiomyopathy

Variability of Left Ventricular Outflow Tract Gradient During Cardiac Catheterization in Patients With Hypertrophic Cardiomyopathy JACC: CARDIOVASCULAR INTERVENTIONS VOL. 4, NO. 6, 2011 2011 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/$36.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2011.02.014 Variability

More information

L Faber, A Meissner, P Ziemssen, H Seggewiss

L Faber, A Meissner, P Ziemssen, H Seggewiss 326 Heart 2000;83:326 331 Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients L Faber, A Meissner, P

More information

A Primer of Disopyramide Treatment of Obstructive Hypertrophic Cardiomyopathy

A Primer of Disopyramide Treatment of Obstructive Hypertrophic Cardiomyopathy Progress in Cardiovascular Diseases 54 (2012) 483 492 www.onlinepcd.com A Primer of Disopyramide Treatment of Obstructive Hypertrophic Cardiomyopathy Mark V. Sherrid a,b,, Milla Arabadjian a a Hypertrophic

More information

Little is known about the degree and time course of

Little is known about the degree and time course of Differential Changes in Regional Right Ventricular Function Before and After a Bilateral Lung Transplantation: An Ultrasonic Strain and Strain Rate Study Virginija Dambrauskaite, MD, Lieven Herbots, MD,

More information

*The first two authors contributed equally to this work

*The first two authors contributed equally to this work Original Research Hellenic J Cardiol 2014; 55: 132-138 Surgical Septal Myectomy for Hypertrophic Cardiomyopathy in Greece: A Single-Center Initial Experience Georgios K. Efthimiadis 1*, Antonis Pitsis

More information

Utility of Two-Dimensional and Doppler Echocardiography in Dual-Chamber Pacing for the Cardiomyopathies

Utility of Two-Dimensional and Doppler Echocardiography in Dual-Chamber Pacing for the Cardiomyopathies Arq Bras Cardiol Conferência Nishimura e col Utility of Two-Dimensional and Doppler Echocardiography in Dual-Chamber Pacing for the Cardiomyopathies Rick Nishimura, John Symanski, David Hurrell, A. Jamil

More information

PROSTHETIC VALVE BOARD REVIEW

PROSTHETIC VALVE BOARD REVIEW PROSTHETIC VALVE BOARD REVIEW The correct answer D This two chamber view shows a porcine mitral prosthesis with the typical appearance of the struts although the leaflets are not well seen. The valve

More information

British Society of Echocardiography

British Society of Echocardiography British Society of Echocardiography Affiliated to the British Cardiac Society A Minimum Dataset for a Standard Adult Transthoracic Echocardiogram From the British Society of Echocardiography Education

More information

Back to Basics: Common Errors In Quantitation In Everyday Practice

Back to Basics: Common Errors In Quantitation In Everyday Practice Back to Basics: Common Errors In Quantitation In Everyday Practice Deborah Agler, ACS, RDCS, FASE October 9, 2017 ASE: Echo Florida Rebecca T. Hahn, MD Director of Interventional Echocardiography Professor

More information

HYPERTROPHIC CARDIOMYOPATHY (HCM) PRESENTED AS UNSTABLE ANGINA COMPLICATED BY SERIOUS VENTRICULAR ARRHYTHMIAS CASE REPORT AND REVIEW LITERATURE

HYPERTROPHIC CARDIOMYOPATHY (HCM) PRESENTED AS UNSTABLE ANGINA COMPLICATED BY SERIOUS VENTRICULAR ARRHYTHMIAS CASE REPORT AND REVIEW LITERATURE HYPERTROPHIC CARDIOMYOPATHY (HCM) PRESENTED AS UNSTABLE ANGINA COMPLICATED BY SERIOUS VENTRICULAR ARRHYTHMIAS CASE REPORT AND REVIEW LITERATURE Lusyun Kumar Yadav * and Jin li Jun Department of Cardiology,

More information

Echocardiographic Evaluation of the Cardiomyopathies. Stephanie Coulter, MD, FACC, FASE April, 2016

Echocardiographic Evaluation of the Cardiomyopathies. Stephanie Coulter, MD, FACC, FASE April, 2016 Echocardiographic Evaluation of the Cardiomyopathies Stephanie Coulter, MD, FACC, FASE April, 2016 Cardiomyopathies (CMP) primary disease intrinsic to cardiac muscle Dilated CMP Hypertrophic CMP Infiltrative

More information

ORIGINAL PAPER. R. C. Steggerda & J. C. Balt & K. Damman & M. P. van den Berg & J. M. ten Berg

ORIGINAL PAPER. R. C. Steggerda & J. C. Balt & K. Damman & M. P. van den Berg & J. M. ten Berg Neth Heart J (2013) 21:504 509 DOI 10.1007/s12471-013-0453-4 ORIGINAL PAPER Predictors of outcome after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. Special interest

More information

Doppler-echocardiographic findings in a patient with persisting right ventricular sinusoids

Doppler-echocardiographic findings in a patient with persisting right ventricular sinusoids Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 1990 Doppler-echocardiographic findings in a patient with persisting right

More information

Myocardial performance index, Tissue Doppler echocardiography

Myocardial performance index, Tissue Doppler echocardiography Value of Measuring Myocardial Performance Index by Tissue Doppler Echocardiography in Normal and Diseased Heart Tarkan TEKTEN, 1 MD, Alper O. ONBASILI, 1 MD, Ceyhun CEYHAN, 1 MD, Selim ÜNAL, 1 MD, and

More information

Despite advances in our understanding of the pathophysiology

Despite advances in our understanding of the pathophysiology Suture Relocation of the Posterior Papillary Muscle in Ischemic Mitral Regurgitation Benjamin B. Peeler MD,* and Irving L. Kron MD,*, *Department of Cardiovascular Surgery, University of Virginia, Charlottesville,

More information

Morphological Determinants of Echocardiographic

Morphological Determinants of Echocardiographic 1570 Morphological Determinants of Echocardiographic Patterns of Mitral Valve Systolic Anterior Motion in Obstructive Hypertrophic Cardiomyopathy Heinrich G. Klues, MD; William C. Roberts, MD; and Barry

More information

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve

More information

B-Mode measurements protocols:

B-Mode measurements protocols: Application Note How to Perform the Most Commonly Used Measurements from the Cardiac Measurements Package associated with Calculations of Cardiac Function using the Vevo Lab Objective The Vevo LAB offline

More information

HYPERTROPHY: Behind the curtain. V. Yotova St. Radboud Medical University Center, Nijmegen

HYPERTROPHY: Behind the curtain. V. Yotova St. Radboud Medical University Center, Nijmegen HYPERTROPHY: Behind the curtain V. Yotova St. Radboud Medical University Center, Nijmegen Disclosure of interest: none Relative wall thickness (cm) M 0.22 0.42 0.43 0.47 0.48 0.52 0.53 F 0.24 0.42 0.43

More information

Hypertrophic Cardiomyopathy Ud Din Shah, MD; DM; FICC; FESC; FACC

Hypertrophic Cardiomyopathy Ud Din Shah, MD; DM; FICC; FESC; FACC 3 Article 1 Physicians Academy January 2018 Hypertrophic Cardiomyopathy Mehraj Ud Din Shah, MD; DM; FICC; FESC; FACC Hypertrophic Cardiomyopathy (HCM) is a genetic disorder which causes clinically unexplained

More information

Adel Hasanin Ahmed 1

Adel Hasanin Ahmed 1 Adel Hasanin Ahmed 1 PERICARDIAL DISEASE The pericardial effusion ends anteriorly to the descending aorta and is best visualised in the PLAX. PSAX is actually very useful sometimes for looking at posterior

More information

The surgical management of hypertrophic obstructive cardiomyopathy with the concomitant mitral valve abnormalities

The surgical management of hypertrophic obstructive cardiomyopathy with the concomitant mitral valve abnormalities Interactive CardioVascular and Thoracic Surgery 21 (2015) 722 726 doi:10.1093/icvts/ivv257 Advance Access publication 15 September 2015 ORIGINAL ARTICLE ADULTCARDIAC Cite this article as: Cui B, Wang S,

More information

Mitral Valve Abnormalities in Hypertrophic Cardiomyopathy: Echocardiographic Features and Surgical Outcomes

Mitral Valve Abnormalities in Hypertrophic Cardiomyopathy: Echocardiographic Features and Surgical Outcomes Mitral Valve Abnormalities in Hypertrophic Cardiomyopathy: Echocardiographic Features and Surgical Outcomes Ryan K. Kaple, BS, Ross T. Murphy, MD, Linda M. DiPaola, BA, Penny L. Houghtaling, MS, Harry

More information

Clinical Course of Hypertrophic Cardiomyopathy With Survival to Advanced Age

Clinical Course of Hypertrophic Cardiomyopathy With Survival to Advanced Age Journal of the American College of Cardiology Vol. 42, No. 5, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00855-6

More information

좌심실수축기능평가 Cardiac Function

좌심실수축기능평가 Cardiac Function Basic Echo Review Course 좌심실수축기능평가 Cardiac Function Seonghoon Choi Cardiology Hallym university LV systolic function Systolic function 좌심실수축기능 - 심근의수축으로심실에서혈액을대동맥으로박출하는기능 실제임상에서 LV function 의의미 1Diagnosis

More information

OPTIMIZING ECHO ACQUISTION FOR STRAIN AND DIASTOLOGY

OPTIMIZING ECHO ACQUISTION FOR STRAIN AND DIASTOLOGY OPTIMIZING ECHO ACQUISTION FOR STRAIN AND DIASTOLOGY October 8, 2017 Deborah Agler, ACS, RDCS, FASE Coordinator of Education and Training Cleveland Clinic General Principles Diastology Clinical Data Heart

More information

Uncommon Doppler Echocardiographic Findings of Severe Pulmonic Insufficiency

Uncommon Doppler Echocardiographic Findings of Severe Pulmonic Insufficiency Uncommon Doppler Echocardiographic Findings of Severe Pulmonic Insufficiency Rahul R. Jhaveri, MD, Muhamed Saric, MD, PhD, FASE, and Itzhak Kronzon, MD, FASE, New York, New York Background: Two-dimensional

More information

Congenital. Unicuspid Bicuspid Quadricuspid

Congenital. Unicuspid Bicuspid Quadricuspid David Letterman s Top 10 Aortic Stenosis The victim can be anyone: Echo is the question and the answer!!!! Hilton Head Island Echocardiography Conference 2012 Timothy E. Paterick, MD, JD, MBA Christopher

More information

LV FUNCTION ASSESSMENT: WHAT IS BEYOND EJECTION FRACTION

LV FUNCTION ASSESSMENT: WHAT IS BEYOND EJECTION FRACTION LV FUNCTION ASSESSMENT: WHAT IS BEYOND EJECTION FRACTION Jamilah S AlRahimi Assistant Professor, KSU-HS Consultant Noninvasive Cardiology KFCC, MNGHA-WR Introduction LV function assessment in Heart Failure:

More information

Hypertrophic Obstructive Cardiomyopathy

Hypertrophic Obstructive Cardiomyopathy The new england journal of medicine clinical practice Hypertrophic Obstructive Cardiomyopathy Rick A. Nishimura, M.D., and David R. Holmes, Jr., M.D. This Journal feature begins with a case vignette highlighting

More information

Inspiratory Right Ventricular Outflow Obstruction in a Patient with Hypertrophic Cardiomyopathy

Inspiratory Right Ventricular Outflow Obstruction in a Patient with Hypertrophic Cardiomyopathy Case Reports Inspiratory Right Ventricular Outflow Obstruction in a Patient with Hypertrophic Cardiomyopathy Kazufumi TSUCHIHASHI, M.D., Akihito TSUCHIDA, M.D., Nobuichi HIKITA, M.D., Shuji YONEKURA, M.D.,

More information

Patients with hypertrophic cardiomyopathy (HCM) and an

Patients with hypertrophic cardiomyopathy (HCM) and an Role of Transcoronary Ablation of Septal Hypertrophy in Patients With Hypertrophic Cardiomyopathy, New York Heart Association Functional Class III or IV, and Outflow Obstruction Only Under Provocable Conditions

More information

Interventional Cardiology

Interventional Cardiology hic Review Interventional Cardiology Septal reduction therapies in hypertrophic cardiomyopathy: comparison of surgical septal myectomy and alcohol septal ablation Abstract Left ventricular outflow tract

More information

Aortic stenosis (AS) is common with the aging population.

Aortic stenosis (AS) is common with the aging population. New Insights Into the Progression of Aortic Stenosis Implications for Secondary Prevention Sanjeev Palta, MD; Anita M. Pai, MD; Kanwaljit S. Gill, MD; Ramdas G. Pai, MD Background The risk factors affecting

More information

Diastolic Function: What the Sonographer Needs to Know. Echocardiographic Assessment of Diastolic Function: Basic Concepts 2/8/2012

Diastolic Function: What the Sonographer Needs to Know. Echocardiographic Assessment of Diastolic Function: Basic Concepts 2/8/2012 Diastolic Function: What the Sonographer Needs to Know Pat Bailey, RDCS, FASE Technical Director Beaumont Health System Echocardiographic Assessment of Diastolic Function: Basic Concepts Practical Hints

More information

Effect of Septal Ablation on Myocardial Relaxation and Left Atrial Pressure in Hypertrophic Cardiomyopathy

Effect of Septal Ablation on Myocardial Relaxation and Left Atrial Pressure in Hypertrophic Cardiomyopathy JACC: CARDIOVASCULAR INTERVENTIONS VOL. 1, NO. 5, 2008 2008 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/08/$34.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2008.07.004 Effect of

More information

Coexistence of asymmetric septal hypertrophy and aortic valve disease in adults

Coexistence of asymmetric septal hypertrophy and aortic valve disease in adults Thorax, 1979, 34, 91-95 Coexistence of asymmetric septal hypertrophy and aortic valve disease in adults M V J RAJ, V SRINIVAS, I M GRAHAM, AND D W EVANS From the Regional Cardiac Unit, Papworth Hospital,

More information

Hypertrophic Cardiomyopathy: Patient Management in 2018

Hypertrophic Cardiomyopathy: Patient Management in 2018 Hypertrophic Cardiomyopathy: Patient Management in 2018 Mackram F. Eleid, MD Giornate Cardiologeche Torinesi October 26, 2018 2018 MFMER slide-1 Disclosures No relevant financial relationships to disclose

More information

8/31/2016. Mitraclip in Matthew Johnson, MD

8/31/2016. Mitraclip in Matthew Johnson, MD Mitraclip in 2016 Matthew Johnson, MD 1 Abnormal Valve Function Valve Stenosis Obstruction to valve flow during that phase of the cardiac cycle when the valve is normally open. Hemodynamic hallmark - pressure

More information

Tissue Doppler and Strain Imaging

Tissue Doppler and Strain Imaging Tissue Doppler and Strain Imaging Steven J. Lester MD, FRCP(C), FACC, FASE Relevant Financial Relationship(s) None Off Label Usage None 1 Objective way with which to quantify the minor amplitude and temporal

More information

Hypertrophic cardiomyopathy (HCM) is a common genetic. Imaging

Hypertrophic cardiomyopathy (HCM) is a common genetic. Imaging Imaging Mitral Valve Abnormalities Identified by Cardiovascular Magnetic Resonance Represent a Primary Phenotypic Expression of Hypertrophic Cardiomyopathy Martin S. Maron, MD; Iacopo Olivotto, MD; Caitlin

More information

Managing Hypertrophic Cardiomyopathy with Imaging. Gisela C. Mueller University of Michigan Department of Radiology

Managing Hypertrophic Cardiomyopathy with Imaging. Gisela C. Mueller University of Michigan Department of Radiology Managing Hypertrophic Cardiomyopathy with Imaging Gisela C. Mueller University of Michigan Department of Radiology Disclosures Gadolinium contrast material for cardiac MRI Acronyms Afib CAD Atrial fibrillation

More information

Left atrial function. Aliakbar Arvandi MD

Left atrial function. Aliakbar Arvandi MD In the clinic Left atrial function Abstract The left atrium (LA) is a left posterior cardiac chamber which is located adjacent to the esophagus. It is separated from the right atrium by the inter-atrial

More information

Echocardiographic Assessment of. Obstructive Hypertrophic Cardiomyopathy Anatomic Validation From Mitral Valve Specimen

Echocardiographic Assessment of. Obstructive Hypertrophic Cardiomyopathy Anatomic Validation From Mitral Valve Specimen 548 Echocardiographic Assessment of Mitral Valve Size in Obstructive Hypertrophic Cardiomyopathy Anatomic Validation From Mitral Valve Specimen Heinrich G. Klues, MD; Michael A. Proschan, PhD; Allan L.

More information

Basic Approach to the Echocardiographic Evaluation of Ventricular Diastolic Function

Basic Approach to the Echocardiographic Evaluation of Ventricular Diastolic Function Basic Approach to the Echocardiographic Evaluation of Ventricular Diastolic Function J A F E R A L I, M D U N I V E R S I T Y H O S P I T A L S C A S E M E D I C A L C E N T E R S T A F F C A R D I O T

More information

Journal of the American College of Cardiology Vol. 33, No. 4, by the American College of Cardiology ISSN /99/$20.

Journal of the American College of Cardiology Vol. 33, No. 4, by the American College of Cardiology ISSN /99/$20. Journal of the American College of Cardiology Vol. 33, No. 4, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(98)00673-1 PERSPECTIVE

More information

Tissue Doppler and Strain Imaging

Tissue Doppler and Strain Imaging Tissue Doppler and Strain Imaging Steven J. Lester MD, FRCP(C), FACC, FASE Relevant Financial Relationship(s) None Off Label Usage None 1 Objective way with which to quantify the minor amplitude and temporal

More information

Case Presentation: A 58-yearold

Case Presentation: A 58-yearold CLINICIAN UPDATE Role of Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy Carey D. Kimmelstiel, MD; Barry J. Maron, MD Case Presentation: A 58-yearold diabetic man was referred for

More information

How to assess ischaemic MR?

How to assess ischaemic MR? ESC 2012 How to assess ischaemic MR? Luc A. Pierard, MD, PhD, FESC, FACC Professor of Medicine Head, Department of Cardiology University Hospital Sart Tilman, Liège ESC 2012 No conflict of interest Luc

More information

Interventional Imaging Cases

Interventional Imaging Cases Interventional Imaging Cases Steven A. Goldstein MD Professor of Medicine Georgetown University Medical Center MedStar Heart Institute Washington Hospital Center Tuesday, October 10, 2017 DISCLOSURE I

More information

Giovanni Di Salvo MD, PhD, FESC Second University of Naples Monaldi Hospital

Giovanni Di Salvo MD, PhD, FESC Second University of Naples Monaldi Hospital Giovanni Di Salvo MD, PhD, FESC Second University of Naples Monaldi Hospital VSD is one of the most common congenital cardiac abnormalities in the newborn. It can occur as an isolated finding or in combination

More information

Three-dimensional Wall Motion Tracking:

Three-dimensional Wall Motion Tracking: Three-dimensional Wall Motion Tracking: A Novel Echocardiographic Method for the Assessment of Ventricular Volumes, Strain and Dyssynchrony Jeffrey C. Hill, BS, RDCS, FASE Jennifer L. Kane, RCS Gerard

More information

Pediatric Echocardiography Examination Content Outline

Pediatric Echocardiography Examination Content Outline Pediatric Echocardiography Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 Anatomy and Physiology Normal Anatomy and Physiology 10% 2 Abnormal Pathology and Pathophysiology

More information

The Murmur of Dynamic Subortic Stenosis Recognition through a Novel Graphic Display

The Murmur of Dynamic Subortic Stenosis Recognition through a Novel Graphic Display International Journal of Clinical Medicine, 2012, 3, 419-425 http://dx.doi.org/10.4236/ijcm.2012.35078 Published Online September 2012 (http://www.scirp.org/journal/ijcm) 1 The Murmur of Dynamic Subortic

More information

Hypertrophic Cardiomyopathy Phenotype Revisited After 50 Years With Cardiovascular Magnetic Resonance

Hypertrophic Cardiomyopathy Phenotype Revisited After 50 Years With Cardiovascular Magnetic Resonance Journal of the American College of Cardiology Vol. 54, No. 3, 2009 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.05.006

More information

Strain/Untwisting/Diastolic Suction

Strain/Untwisting/Diastolic Suction What Is Diastole and How to Assess It? Strain/Untwisting/Diastolic Suction James D. Thomas, M.D., F.A.C.C. Cardiovascular Imaging Center Department of Cardiology Cleveland Clinic Foundation Cleveland,

More information

We present the case of an asymptomatic, 75-year-old

We present the case of an asymptomatic, 75-year-old Images in Cardiovascular Medicine Asymptomatic Rupture of the Left Ventricle Lech Paluszkiewicz, MD; Stefan Ożegowski, MD; Mohammad Amin Parsa, MD; Jan Gummert, PhD, MD We present the case of an asymptomatic,

More information

Hypertrophic Cardiomyopathy: beyond gradient and wall thickness

Hypertrophic Cardiomyopathy: beyond gradient and wall thickness Hypertrophic Cardiomyopathy: beyond gradient and wall thickness Michael H. Picard, M.D. Massachusetts General Hospital Harvard Medical School no disclosures special thanks to A. Baggish 1 Hypertrophic

More information

Echocardiographic Evaluation of Mitral Annulus Excursion in Normal Horses

Echocardiographic Evaluation of Mitral Annulus Excursion in Normal Horses Echocardiographic Evaluation of Mitral Annulus Excursion in Normal Horses Carlos Lightowler, DVM a Giuseppe Piccione, DVM b Maria Laura Cattaneo, DSS c Elisabetta Giudice, DVM, PhD d a Departamento de

More information

Steel vs Alcohol. Or Neither. Management of Hypertrophic Cardiomyopathy. Josh Doll, MD January 24, 2015

Steel vs Alcohol. Or Neither. Management of Hypertrophic Cardiomyopathy. Josh Doll, MD January 24, 2015 Steel vs Alcohol Or Neither Management of Hypertrophic Cardiomyopathy Josh Doll, MD January 24, 2015 47yo Male, Mr. L Severe progressive dyspnea on exertion and weight gain Previous avid Cross-Fit participant

More information

Cardiac hypertrophy : differentiating disease from athlete

Cardiac hypertrophy : differentiating disease from athlete Cardiac hypertrophy : differentiating disease from athlete Ario Soeryo Kuncoro, MD, Cardiologist Echocardiography Division, National Cardiovascular Centre Harapan Kita-Jakarta Departement of Cardiology

More information

December 2018 Tracings

December 2018 Tracings Tracings Tracing 1 Tracing 4 Tracing 1 Answer Tracing 4 Answer Tracing 2 Tracing 5 Tracing 2 Answer Tracing 5 Answer Tracing 3 Tracing 6 Tracing 3 Answer Tracing 6 Answer Questions? Contact Dr. Nelson

More information

Muscle dynamics in hypertrophic cardiomyopathy

Muscle dynamics in hypertrophic cardiomyopathy Postgraduate Medical Journal (1986) 62, 545-551 Muscle dynamics in hypertrophic cardiomyopathy Roando F. Alvares and John F. Goodwin Division ofcardiovascular Diseases, Hammersmith Hospital, London W12,

More information

The Electrocardiogram part II. Dr. Adelina Vlad, MD PhD

The Electrocardiogram part II. Dr. Adelina Vlad, MD PhD The Electrocardiogram part II Dr. Adelina Vlad, MD PhD Basic Interpretation of the ECG 1) Evaluate calibration 2) Calculate rate 3) Determine rhythm 4) Determine QRS axis 5) Measure intervals 6) Analyze

More information

Global and Regional Myocardial Function Quantification by Two-Dimensional Strain Application in Hypertrophic Cardiomyopathy

Global and Regional Myocardial Function Quantification by Two-Dimensional Strain Application in Hypertrophic Cardiomyopathy Journal of the American College of Cardiology Vol. 47, No. 6, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.10.061

More information